SEARCH

SEARCH BY CITATION

References

  • 1
    Rapaport SI. The multiple faces of the partial thromboplastin time APTT. J Thromb Haemost 2004; 2: 22502.
  • 2
    Vermylen J, Hoylaerts M. The multiple faces of the partial thromboplastin time APTT. J Thromb Haemost 2004; 2: 22523.
  • 3
    Saito H. The multiple faces of the partial thromboplastin time APTT. J Thromb Haemost 2004; 2: 22534.
  • 4
    Hirsh J, Bates S. The multiple faces of the partial thromboplastin time APTT. J Thromb Haemost 2004; 2: 22546.
  • 5
    Dahlbäck B. The multiple faces of the partial thromboplastin time APTT. J Thromb Haemost 2004; 2: 22567.
  • 6
    Poller L. The multiple faces of the partial thromboplastin time APTT. J Thromb Haemost 2004; 2: 22509.
  • 7
    Toh CH, Samis J, Downey C, Walker J, Becker L, Brufatto N, Tejidor L, Jones G, Houdijk W, Giles AR, Koschinsky M, Ticknor LO, Paton R, Wenstone R, Nesheim ME. Biphasic transmittance waveform in the APTT coagulation assay is due to the formation of a Ca2+-dependent complex of C-reactive protein with very low density lipoprotein and is a novel marker of impending disseminated intravascular coagulation. Blood 2002; 100: 25229.
  • 8
    Rowe IF, Soutar AK, Trayner IM, Thompson GR, Pepys MB. Circulating human C-reactive protein binds very low density lipoproteins. Clin Exp Immunol 1984; 58: 23744.
  • 9
    Downey C, Kazmi R, Toh CH. Novel and diagnostically applicable information from optical waveform analysis of blood coagulation in disseminated intravascular coagulation. Br J Haematol 1997; 98: 6873.
  • 10
    Toh CH, Ticknor LO, Downey C, Giles AR, Paton RC, Wenstone R. Early identification of sepsis and mortality risks through simple, rapid clot-waveform analysis. Intensive Care Med 2003; 29: 5561.
  • 11
    Dempfle CEG, Lorenz S, Smolinksi M, Wurst M, West S, Houdijk WPM, Quintel M, Borggrefe M. Utility of activated partial thromboplastin time waveform analysis for identification of sepsis and overt disseminated intravascular coagulation in patients admitted to a surgical intensive care unit. Crit Care Med 2004; 32: 5204.
  • 12
    Bakhtiari K, Meijers JC, de Jonge E, Levi M. Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med 2004; 32: 241621.
  • 13
    Dennis MW, Downey C, Bruffato N, Nesheim ME, Stevenson K, Toh CH. Prothrombinase enhancement through quantitative and qualitative changes affecting very low density lipoprotein in complex with C-reactive protein. Thromb Haemost 2004; 91: 52230.
  • 14
    Reddy NM, Hall SW, MacKintosh FR. Partial thromboplastin time: prediction of adverse events and poor prognosis by low abnormal values. Arch Intern Med 1999; 159: 270610.
  • 15
    Tripodi A, Chantarangkul V, Martinelli I, Bucciarelli P, Mannucci PM. A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism. Blood 2004; 104: 36314.
  • 16
    White GC II. The partial thromboplastin time: defining an era in coagulation. J Thromb Haemost 2003; 1: 226770.